-

INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – MXIM, JCAP, GLIBA, PFNX

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating:

Maxim Integrated Products, Inc. (NASDAQ: MXIM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Analog Devices, Inc. Under the terms of the agreement, Maxim stockholders will receive 0.630 of a share of Analog Devices common stock for each share of Maxim common stock they hold at closing. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/maxim-integrated-products-inc-mxim-stock-merger-analog-devices-adi/.

Jernigan Capital, Inc. (NYSE: JCAP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to an affiliate of NexPoint Advisors, L.P. Under the terms of the agreement, Jernigan Capital common stockholders will receive $17.30 per share in cash. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/jernigan-capital-inc-stock-merger-jcap-nexpoint/.

GCI Liberty, Inc. (NASDAQ: GLIBA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Liberty Broadband Corporation. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/gci-liberty-inc-gliba-stock-merger-liberty-broadband-technologies/.

Pfenex Inc. (NYSE: PFNX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the merger agreement, Pfenex shareholders will receive $12.00 per share in cash. In addition, Ligand will pay Pfenex shareholders $2.00 per share as a Contingent Value Right in the event a predefined regulatory milestone is achieved by December 31, 2021. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/pfenex-inc/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLP

NASDAQ:MXIM

Release Versions

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLP

ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Esperion Therapeutics, Inc. (NASDAQ: ESPR) to funds managed by ARCHIMED for $3.16 per share in cash and the right to participate in contingent milestone payments. Halper Sadeh encourages Esperion shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com....

KALV Stock Alert: Halper Sadeh LLC is Investigating Whether KalVista Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) to Chiesi Group for $27.00 per share in cash. Halper Sadeh encourages KalVista shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether KalVista and its board of directors...

REAX Stock Alert: Halper Sadeh LLC is Investigating Whether The Real Brokerage Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of The Real Brokerage Inc. (NASDAQ: REAX) and RE/MAX Holdings, Inc. for 1 share of the combined company for each Real share. Upon closing of the proposed transaction, Real shareholders are expected to own approximately 59% of the combined company. Halper Sadeh encourages Real shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free o...
Back to Newsroom